InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Renschler Markus Md. Director active across 1 company, notably Cyteir Therapeutics, Inc.. In total, 5 disclosures have been logged. History available since 21 December 2022. The latest transaction was filed on 29 February 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
RENSCHLER MARKUS MD is linked to Cyteir Therapeutics, Inc., where the listed role is President and CEO. He has 5 filings in total, all within the sampled filings, covering the period from 2022-12-23 to 2024-03-05, and the modal transaction nature is option exercise.